SARA MASON: Open Payments
NPI 1013573260 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,801 in 178 payments from 20 companies in 2025. Trend: 2023 $2,473 · 2024 $2,408 · 2025 $2,801
Food & beverage: $2,690Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $400 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $326 |
| Axsome Therapeutics, Inc. | 19 | $297 |
| Vanda Pharmaceuticals Inc. | 17 | $287 |
| Alkermes, Inc. | 16 | $224 |
| Teva Pharmaceuticals USA, Inc. | 7 | $199 |
| HARMONY BIOSCIENCES LLC | 14 | $191 |
| E.R. Squibb & Sons, L.L.C. | 9 | $179 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $153 |
| Otsuka America Pharmaceutical, Inc. | 5 | $107 |
Products named: CAPLYTA, Auvelity, VRAYLAR, WAKIX, COBENFY, ARISTADA, FANAPT, TRINTELLIX.
Industry payments across NE — which companies pay providers there.
